参考文献/References:
［1］ Capodanno D, Ministeri M, Cumbo S, et al. Volume to creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast induced nephropathy［J］. Catheter Cardiovasc Interv, 2014, 83: 907 912.
［2］ Abe M, Morimoto T, Akao M, et al. Relation of contrast induced nephropathy to long term mortality after percutaneous coronary intervention［J］. Am J Cardiol, 2014, 114: 362 368.
［3］ 潘静薇， 陆志刚， 张佳胤， 等． 冠状动脉介入治疗后迟发型对比剂肾病［J］． 介入放射学杂志， 2013， 22： 15 19．
［4］ 张贵春. 丹参川芎嗪对血瘀型冠心病患者PCI术后肾脏保护作用的临床研究［D］. 福建： 福建中医药大学. 2013： 1 32.
［5］ 刘福颂， 王 伟． 造影剂过敏致死亡6例分析［J］． 中国医药导报， 2010， 7： 180．
［6］ Kalaiselvan V, Sharma S, Singh GN. Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India［J］. Drug Saf, 2014, 37: 703 710.
［7］ 池菊芳， 郭航远， 彭 放， 等． 经皮冠状动脉介入治疗术后长期联合阿司匹林和氯吡格雷抗血小板治疗的安全性评价［J］． 中国全科医学， 2008， 11： 1254 1256．
［8］ Golshahi J, Nasri H, Gharipour M. Contrast induced nephropathy; A literature review［J］. J Nephropathol, 2014. 3: 51 56.
［9］ Burgess WP, Walker PJ. Mechanisms of contrast induced nephropathy reduction for saline (NaCl) and Sodium bicarbonate(NaHCO3)［J］. Biomed Res Int, 2014: 510385.
［10］ Ivanes F, Isorni MA, Halimi JM, et al. Predictive factors of contrast induced nephropathy in patients undergoing primary coronary angioplasty［J］. Arch Cardiovasc Dis, 2014, 107: 424 432.
［11］ Yang K, Liu W, Ren W, et al. Different interventions in preventing contrast induced nephropathy after percutaneous coronary intervention［J］. Int Urol Nephrol, 2014, 46: 1801 1807.
［12］ 舒 冰， 周重建， 马迎辉， 等． 中药川芎中有效成分的药理作用研究进展［J］． 中国药理学通报， 2006， 22： 1043 1047．
［13］ 曾聪彦， 梅全喜． 川芎嗪致30例不良反应文献分析［J］． 中国药房， 2008， 19： 1908 1910．
［14］ 张志彬． 川芎嗪静脉滴注致严重低血压1例［J］． 中国药业， 2002， 11： 79．
［15］ 吴广通， 石力夫， 余建国． 超临界流体萃取法对川芎挥发油成分的研究［J］． 药学服务与研究， 2001， 1： 61 62．
相似文献/References:
[1]倪靖炜,张瑞岩,张建盛,等.非离子型双体对比剂在冠状动脉介入治疗中应用的安全性观察[J].介入放射学杂志,2006,(06):327.
NI Jing-wei,ZHANG Rui-yan,ZHANG Jian-sheng,et al.Safety of isosomolar nonionic dimmer during percutaneous coronary intervention[J].journal interventional radiology,2006,(02):327.
[2]张 蛟,段媛媛,金至赓,等.双轴旋转造影在老年冠心病诊断中的安全性可行性研究[J].介入放射学杂志,2014,(09):757.
ZHANG Jiao,DUAN Yuan yuan,JIN Zhi geng,et al.The safety and feasibility of dual axis rotational angiography for the diagnosis of coronary artery disease in aged Chinese patients[J].journal interventional radiology,2014,(02):757.
[3]王春梅,谷涌泉,李建新,等. 糖尿病足介入治疗围手术期处理[J].介入放射学杂志,2013,(09):780.
WANG Chun? mei,GU Yong? quan,LI Jian? xin,et al. Perioperative management of interventional therapy for diabetic foot[J].journal interventional radiology,2013,(02):780.
[4]王玉萍,沈世林,苏东君,等.对比剂肾病研究进展 [J].介入放射学杂志,2017,(06):572.
WANG Yuping,SHEN Shilin,SU Dongjun,et al.Research progress in contrast- induced nephropathy[J].journal interventional radiology,2017,(02):572.
[5]黄 剑,周大勇,沈利明,等.二氧化碳造影在下肢动脉腔内治疗中的应用 [J].介入放射学杂志,2018,27(03):211.
HUANG Jian,ZHOU Dayong,SHEN Liming,et al.Application of manual carbon dioxide angiography in endovascular treatment for arteriosclerosis obliterans of lower extremity in patients with renal insufficiency or iodine allergy[J].journal interventional radiology,2018,27(02):211.
[6]卢海燕,吕玲春,沈珈谊,等.氨基末端脑钠肽前体与冠状动脉造影后对比剂肾病相关性研究 [J].介入放射学杂志,2018,27(09):817.
LU Haiyan,LV Lingchun,SHEN Jiayi,et al.Correlation between N- terminal pro- brain natriuretic peptide levels and contrast- induced nephropathy in patients after receiving coronary angiography： a clinical study[J].journal interventional radiology,2018,27(02):817.
[7]赵凯凯,司友娇,黄九宁,等.肝癌患者TACE术后对比剂肾病的危险因素[J].介入放射学杂志,2019,28(10):942.
ZHAO Kaikai,SI Youjiao,HUANG Jiuning,et al.The risk factors for contrast- induced nephropathy in patients with HCC after TACE[J].journal interventional radiology,2019,28(02):942.